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Abstract
Purpose The aim of this study was to determine outcomes of
total hip replacement (THR) with the Lemania cemented
femoral stem.
Methods A total of 78 THR patients were followed and
compared to 17 “fit”, healthy, elderly and 72 “frail” elderly
subjects without THR, using clinical outcome measures and
a portable, in-field gait analysis device at five and ten years
follow-up.
Results Forty-one patients (53 %), mean age 83.4 years, avail-
able at ten years follow-up, reported very good to excellent
satisfaction. Mean Harris Hip and Western Ontario and
McMaster Universities Osteoarthritis Index (WOMAC) scores
were 81.2 and 10.5 points, respectively, with excellent radio-
logical preservation of proximal femur bone stock. Spatial and
temporal gait parameters were close to the fit group and better
than the frail group.
Conclusions Lemania THR demonstrated very good, stable
clinical and radiological results at ten years in an older patient
group, comparable to other cemented systems for primary
THR. Gait analysis confirmed good walking performance in
a real-life environment.
Keywords Total hip replacement . Cemented stem .
Anatomic femoral stem . Gait analysis . Outcome . Geriatric
population
Introduction
Total hip replacement (THR) is an established surgical treat-
ment for advanced hip osteoarthritis, with a low complication
rate and survival rates of 94 % at 10 years and 78–87 % at
25 years [1]. Different stem philosophies, surface finishes,
cementing and surgery techniques, and a wide choice of
implants are available.
Encouraging short-term results prompted widespread use
of several cemented prostheses, but long-term results proved
less than satisfactory [2, 3]. A clinical need and economic
demand to improve implants has encouraged the development
of a less expensive implant with an equal or higher survival
rate. The Lemania™ femoral stem (Symbios, Yverdon-les-
Bains, Switzerland), introduced in 1999, proposes a biome-
chanical advantage and is produced at 25 % lower cost than
equivalent cemented stems. The smooth, polished, collarless
and symmetrical stainless steel stem has a unique design that
fills most of the proximal femur metaphysis and better dis-
perses loads to bone [4]. Outcomes with the Lemania stem
have not yet been reported.
Traditional outcome measures to assess THR include the
Harris Hip Score (HHS) [5], the Western Ontario and
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McMaster Universities Osteoarthritis Index (WOMAC)
[6] and general quality of life questionnaires such as the
EuroQol in five dimensions (EQ-5D) [7]. These scores
correlate poorly with the real walking performance of
patients, which can be assessed objectively with gait
analysis [8]. Most gait analysis techniques are expensive,
complicated and require a gait laboratory with specially
trained staff or interfere with the patient’s gait [9]. Hence,
lighter, portable, easy-to-use, ambulatory gait recording
systems have been developed [10].
We determined subjective and objective outcomes of THR
with the cemented Lemania stem, using traditional outcome
measures and a portable, in-field gait analysis device at five
and ten years follow-up.
Materials and methods
In this prospective cohort study, osteoarthritis patients aged
≥65 years requiring THR were recruited at a large, urban
hospital fromMarch 1999 to October 2000. Patients provided
informed consent prior to study enrolment. Gait performance
was compared to two reference populations: (1) “fit elder-
ly”—17 selected individuals (mean age 77.5 years, range 71–
88) with no health problems and (2) “frail elderly”—72 pa-
tients (mean age 82.0 years, range 63–98) hospitalised at a
rehabilitation centre for three weeks for health problems un-
related to the lower limb, who performed the gait trial prior to
discharge. The Research Ethics Board of our institution ap-
proved this study.
Primary THR for primary or secondary coxarthrosis was
performed by a senior surgeon using a standardised operative
technique. Patients received the collarless cemented Lemania
stem and the Hilock™ (Symbios, Yverdon-les-Bains,
Switzerland) press-fit cup using a posterolateral approach.
The femoral diaphysis was washed under pressure with phys-
iological serum after implantation of the cement stopper
(Cemstop™, Teknimed, France) using the OrthoLav™ sys-
tem (Stryker, Kalamazoo, MI, USA). Retrograde stem cemen-
tation was performed under drain aspiration with gentamicin-
impregnated cement AKZ™ (Howmedica, Mahwah, NJ,
USA). Patients were mobilised to a bedside seat on the first
post-operative day and began walking with crutches, without
weight-bearing restrictions, on the second day. Patients re-
ceived physical therapy for one week and walked with
crutches for six weeks.
Clinical follow-up Patients were evaluated by an independent
observer before and one, five and ten years after THR. Preop-
erative HHS and WOMAC scores were calculated. Clinical
examinations included physical examination, documentation
of complications and HHS, WOMAC and EQ-5D question-
naires. Pain and stiffness in the operated limb were evaluated
using visual analogue scales (VAS). Patients also completed a
satisfaction questionnaire.
Radiological follow-up Radiological assessment after each
follow-up visit included anteroposterior and axial view ra-
diographs of the pelvis. All radiological analyses were per-
formed by the same independent trained observer. Cup incli-
nation and anteversion, caput-collum-diaphyseal (CCD) an-
gle and prosthesis neck anteversion were calculated. The
femur was analysed for osteolysis zones, defined as newly
developed radiolucent lines >2 mm at the cement-bone in-
terface. Stem subsidencewasmeasured as a vertical increase
of >2 mm of radiolucency created by distal migration of the
prosthesis shoulder from any overlapping cement in Gruen
zone 1. Calcar bone resorption, diaphyseal cortical hypertro-
phy and fractures of the cement mantle were assessed. The
modified Brooker classificationwas used to describe hetero-
topic ossifications [11].
Objective gait analysis Objective gait analysis at five and
ten years after surgery used the Physilog® ambulatory in-
field system (BioAGM, La Tour-de-Peilz, Switzerland). A
lightweight (300 g) portable recorder was placed on the waist
belt, with four miniature gyroscopes (ADXRS150, Analog
Devices Inc., Munich, Germany) attached to each calf and
thigh with Velcro. This system is easy to use and shows good
agreement with a gait analysis laboratory reference system
and the HHS [10].
We measured lower limb movement while patients walked
30 metres in a corridor, at a self-selected normal speed. Two
walking trials were recorded and averaged for analysis. Sensor
signals were digitised and stored by the Physilog recorder for
offline 2D gait analysis [10].
Statistical analysis Non-parametric tests were used due to the
asymmetrical distribution of most variables. The Wilcoxon
signed rank test was used for paired comparison (i.e. same
patient at different times). The Wilcoxon rank sum test was
used for unpaired comparison (i.e. reference population versus
patients). A p value <0.05 was considered significant.
Results
Eighty-four patients received a Lemania THR. In the first
year, four patients died for reasons unrelated to the surgery,
one was lost to follow-up and one declined to participate
retroactively. The mean age at surgery of the 78 remaining
patients (74 % women) was 75.6 years (range 62–91).
We reviewed 39 patients (72 % women) clinically and
radiologically at five years (range 5.1–7.0) follow-up
(Fig. 1). Of these patients, 22 (28 %) had died for reasons
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unrelated to the THR, two (3%) were lost to follow-up and 15
(19 %) were not examined due to health reasons unrelated to
the surgery. Gait was analysed in 28 patients with a mean age
of 79.2 years (range 67–96). Patients who received a contra-
lateral THR during the follow-up period or could not perform
the walking trials due to health reasons unrelated to the THR
were excluded from gait analysis. At ten years (range 10.8–
11.8) follow-up, 41 patients (81 % women) were reviewed
clinically and radiologically. Gait was analysed in 29 patients
with a mean age of 83.4 years (range 72–93) (Fig. 1).
Fig. 1 Flow chart presenting the
examined patients and patients
lost to follow-up during the study
Table 1 Clinical outcomes fol-
lowing THR
aWilcoxon signed rank test, testing
the difference between the variable











Total score, mean (range) 63.0 (31–94) 4.9 (0–23) 10.5 (0–50) p <0.001
Pain subscore, mean (range) 17.3 (10–20) 0.8 (0–6) 0.7 (0–8)
HHS
Total score, mean (range) 43.8 (24–56) 84.7 (43–100) 81.2 (49–100) p <0.16
Distance walked subscore, mean (range) 4.2 (2–5) 8.7 (5–11) 8.1 (0–11)
Pain subscore, mean (range) 10.9 (10–20) 40.1 (10–44) 40.3 (10–44)
EQ-5D
VAS, mean (range) 87.5 (75–95) 74.5 (40–100) p =0.003
Level 1 (no problems), %
Mobility 67 50
Self-care 92 86
Usual (daily) activities 69 71
Pain/discomfort 87 82
Anxiety/depression 100 82
Level 2 (some problems), %
Mobility 33 50
Self-care 8 11
Usual (daily) activities 31 27
Pain/discomfort 13 18
Anxiety/depression 0 18
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Clinical results The EQ-5D, HHS and WOMAC results are
summarised in Table 1. The difference between five and
ten years follow-up was statistically significant for the
WOMAC total score and EQ-5D VAS score, with better
scores at five years follow-up.
For the EQ-5D, most patients reported no problems
(level 1) for the various domains, some reported some prob-
lems (level 2) and one patient (2.3%) reported level 3 problems
for self-care and usual activity. The EQ-5D scores are compared
to EQ-5D norm scores in the general population ≥80 years [7]
in Fig. 2.
Total HHS are shown in Fig. 3. The mean walked distance
was a maximum of 500 metres pre-operatively (4.2 points,
range 2–5) and improved to >500 m at five years (8.7 points,
range 5––11) and ten years (8.2 points, range 0–11) follow-up.
The difference between preoperative and five years follow-up
was significant (p <0.05), but between five and ten years
follow-up was not (p =0.16). At ten years follow-up, 34 %
of THR were rated excellent, and 22 % were rated good.
At ten years follow-up, 95 % of patients were satisfied or
very satisfied with the surgery. Pain relief was excellent: 34
patients (83 %) had no pain in the operated hip, five (12 %) had
Fig. 2 The EQ-5D score at
10 years follow-up, compared to
the reference population of people
age 80 years and older (80+) (EQ-
5D norms table for national
population [7]). Values are
percentages
Fig. 3 Evolution of WOMAC and HHS during follow-up
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occasional mild pain (VAS=2 or 3) and one (2 %) complained
of occasional moderate pain (VAS=5).
Radiological results At ten years follow-up, mean cup incli-
nation was 49.9° (range 36–65°), and mean cup anteversion
was 29.2° (range 12–46°). The mean CCD angle was 132.4°
(range 123–140°), and mean anteversion of the stem neck was
10.1° (range −4 to 38°).
Radiolucent lines >2 mm were found around the stem in
11 cases (27 %). Stem subsidence occurred in four cases, of
which one presented with stem subsidence >20 mm, a distal
cement fracture and radiolucent lines at the stem-cement
interface. This woman had few symptoms (VAS pain=0,
VAS stiffness=0) and a good clinical outcome with total
WOMAC score of 24 points. There were no cases of calcar
resorption greater than grade I and five cases (12 %) of
cortical hypertrophy (one patient in Gruen zone 3, three
patients in zone 5 and one patient in zones 3 and 5). Hetero-
topic ossificationswere identified in seven (17%) patients—
six with Brooker grade I and one with Brooker grade III. All
patients with the above-described radiological changes were
asymptomatic.
Gait analysis Mean spatial and temporal gait parameters at
five and ten years follow-up and for the fit elderly and frail
elderly reference populations are summarised in Table 2.
There was a significant difference between all groups for each
parameter (p <0.001). A significant deterioration of every gait
parameter was observed between five and ten years follow-up.
With advancing age, THR patients walked with slower ca-
dence and speed and shortened stride length. Single and
double stance phases increased with advancing age. Range of
motion (ROM) for each limb segment also decreased with age.
Discussion
Clinical outcome measures and gait analysis results were very
good at five and ten years following THR with the cemented
Lemania stem. Gait analysis was performed while patients
walked freely for 30 metres in a corridor, and the results were
compared to reference populations representing two ex-
tremes—a fit elderly and a frail elderly population. No other
study on outcomes with this anatomic femoral stem has been
published to date.
Table 2 Spatial and temporal
gait parameters
Double support and stance are
expressed as percentage of gait
cycle time. Significant differences
were observed between each









Cadence (steps/min) 112.63±10.04 102.77±11.05 99.09±11.88 75.63±14.78
Stance (%) 59.02±2.09 61.52±2.49 62.48±2.45 67.79±5.41
Double support (%) 18.03±4.18 23.03±4.97 24.96±4.91 36.06±10.55
Stride length (m) 1.28±0.11 1.13±0.18 1.00±0.15 0.81±0.17
Speed (m/s) 1.20±0.16 0.97±0.20 0.83±0.15 0.52±0.17
Shank (°) 70.57±4.07 65.83±7.95 58.99±6.49 47.80±9.15
Thigh (°) 42.32±4.41 41.82±5.92 34.24±5.20 26.65±5.86
Knee (°) 52.29±5.03 53.85±6.71 46.39±6.40 35.34±7.84
Table 3 Comparison of HHS af-
ter THR, at long-term follow-up,
in the literature
Values are mean (range) in points
or mean ± SD
Authors Stem Follow-up
(years)
HHS pre-op HHS at final
follow-up
This study Lemania 9.7 43.8 (24–56) 81.2 (49–100)
Bjørgul et al. [13] Charnley 10 48.3 89.8
Chandran et al. [22] Charnley 14 23.4 (13–42) 89.1 ±1.18
Chiu et al. [27] Exeter 12.8 39.8 (20–62) 82.3 (42–92)
Hulleberg et al. [28] Charnley 13 83 (29–100)
Lachiewicz and Messick [23] Cemented Zimmer 10 44 (0–70) 86 (30–100)
Nieuwenhuijse et al. [16] Exeter 9.4 31±19 73±23
Stucinskas et al. [24] Müller 16 78±16.3
Riede et al. [14] Müller 10.3 87.3 (55–100)
Williams et al. [25] Exeter 8.9 82 (14–100)
Yates et al. [26] Collarless polished 11 39 (20–61) 86 (47–100)
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Ten years following THR, the EQ-5D score was excellent,
with a mean VAS of 74.5 points, compared to 58 points in the
age-matched healthy reference population [7]. Our study’s
patients reported fewer difficulties for each dimension: 82 %
presented with no pain versus 31 % of the reference popula-
tion, and 71 % reported no difficulty in usual activities versus
58 % of the reference population. HHS and WOMAC scores
improved significantly compared to baseline (Fig. 3). The
magnitude of HHS improvement was comparable to that
reported for other prostheses with similar follow-up (Table 3).
Both HHS and WOMAC scores declined slowly during the
follow-up period (Fig. 3). Patients remained pain free over the
long term, despite a gradual functional decline. Other studies
have noted a gradual decline inHHS following THR (Table 4),
at an average of 0.7 points per year with no medical compli-
cations [12]. Deterioration of functional scores appears to
correspond to a decline in general health due to aging. The
use of instruments other than the HHS to assess activity level
and walking ability in THR patients has been recommended
[13, 14].
The Lemania stem demonstrated good radiological results
at ten years follow-up, with radiolucent lines at the cement-
bone interface in 11 patients (27 %), all asymptomatic. Linear
radiolucency and isolated bone lysis at the cement-bone inter-
face have been reported in up to 30 % of cases at long-term
follow-up [14] and do not necessarily indicate loosening [15].
We found stem subsidence in four asymptomatic patients,
which is often the case in this type of prosthesis design [16].
This finding validates the design of the Lemania stem to
optimally fill the proximal metaphysis and improve proximal
load transfer to the bone.
Table 4 Long-term evolution of the HHS following THR in the literature
Before
THR
1 year 2 years 5 years 10 years 15 years
This study 43.8 96.2 84.7 81.2
Bjørgul et al.
[13]
48.3 90.2 92.7 93.9 89.8
Chandran et al.
[22]
23.4 93.6 93 89.1
Riede et al. [14] 87.3 82.1
Values are mean in points
Fig. 4 Comparison of chosen gait parameters in our study
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Objective gait analysis is useful for locomotor function
evaluation after THR. Most studies evaluated gait at short-
term follow-up, with contradictory findings. Petersen et al.
[17] compared operated and non-operated hips at 12 weeks
post-operatively and reported an asymmetric gait pattern,
with significantly less power produced by muscles around
the operated hip. Nantel and colleagues [18] observed a
return to normalwalking one to four years after THR,where-
as Perron et al. [19] failed to show normal gait at short-term
follow-up. Kyriazis and Rigas [9] found significant differ-
ences in gait at ten years follow-up in THR patients and
controls, suggesting that patients who have undergone
THR do not return to the same normal gait pattern as healthy,
age-matched controls. We found significant differences be-
tween the THR and reference groups in every analysed tem-
poral and spatial parameter at five and ten years follow-up,
with significant deterioration of every gait parameter be-
tween five and ten years (Fig. 4). Our study’s patients had
better gait performance than the frail elderly, but never
achieved the level of the fit elderly patients. The differences
were small and likely difficult to elucidate by physical ex-
amination only. However, objective gait analysis demon-
strated statistically significant differences and confirmed its
utility as a complement to traditional evaluation methods.
Three studies analysed gait parameters of THR patients at a
follow-up of at least ten years (Table 5) [9, 20, 21]. None had
patients walking freely in a corridor (without cameras or
specific walkways) as in our study. The observed decreases
in cadence, stride length, speed and all ROM from five to
ten years follow-up in our study are similar to those reported
by Bennett et al. [20, 21]. However, THR patients in our study
walked faster and with a greater stride length (Table 5). They
also had a better thigh ROM, despite a similar mean age. In
contrast, our patients had a worse gait pattern than that report-
ed by Kyriazis and Rigas [9], with slower speed, slower
cadence and shorter stride length (Table 5). Comparison of
these studies is difficult, due to the substantially younger
patient population in the study byKyriazis and Rigas (60 years
versus 83 years in our cohort). Our good clinical and radio-
logical results suggest that the deterioration in gait pattern
over time is related to advanced age rather than THR.
A strength of this study is that gait analysis was performed
over a relatively long distance of 30 metres, with two walking
trials, which allowed recording of real walking performance
and minimised the effect of better initial gait values produced
by a rested patient. Bennett et al. [20, 21] performed their gait
analysis at one self-selected speed on a walkway with six
cameras. Kyriazis and Rigas [9] used a conductive walkway.
More age-matched controlled trials with a standardised gait
analysis are required for a better understanding of long-term
changes in gait patterns after THR and to improve comparison
of results.
In conclusion, THR with the Lemania stem demonstrated
good, stable clinical and radiological results at ten years
follow-up in a relatively old patient group. Our results are
comparable to those of primary THR with other cemented
systems such as Müller or Exeter. Patients demonstrated good
walking performance ten years following Lemania THR.
Temporal and spatial gait parameters were better than those
of frail, age-matched patients and close to those of a fit, age-
matched population, as measured in a real-life environment.
Clinical outcome scores and gait parameters decrease progres-
sively in patients ≥80 years of age, likely due to the effect of
advancing age rather than THR.
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Table 5 Comparison of chosen gait parameters to other studies












This study (corridor free walking) Lemania THR 9.7 83.3 99.09 62.48 1.00 0.83 34.2 46.4
FRAIL 82.0 75.63 67.79 0.81 0.52 26.7 35.3
FIT 77.5 112.6 59.02 1.28 1.20 42.32 52.3
Bennett et al. [20, 21] (gait lab
with Vicon cameras)
X-press cemented THR 10 84 110.9 64.10 0.88 0.82 30.4 46.7
CON 64 117.2 60.90 1.37 1.34 45.9 57.7
Kyriazis and Rigas [9]
(conductive walkway)
Uncemented THR 10 60 110.2 68.90 1.22 1.12
CON 60 105.2 73.10 1.55 1.36
Boldface indicates statistical difference between THR group and control group. Values for follow-up and age are mean in years
THR total hip replacement group, FRAIL our reference population of 72 elderly frail patients, FIT our reference population of fit patients, CON control
group, ROM range of motion
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